Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice

Infection and Immunity

Volumn 68, Issue 8, 2000, Pages 4765-4768

  Blessing, Erwin ^a   Lin, Tsun Mei ^a,b   Campbell, Lee Ann ^a   Rosenfeld, Michael E ^a   Lloyd, Deborah ^a   Kuo, Cho Chou ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; AORTA ATHEROSCLEROSIS; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; INFLAMMATORY INFILTRATE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; AORTA; ARTERIOSCLEROSIS; ARTERITIS; CARDIOVASCULAR DISEASES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL; MALE; MICE; MICE, INBRED C57BL; MYOCARDITIS; MYOCARDIUM;

EID: 0033929469     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.8.4765-4768.2000     Document Type: Article

References (23)

1. Breslow, J. L. 1996. Mouse models of atherosclerosis. Science 272:685-688.
2. Campbell, L. A., T. C. Moazed, C. C. Kuo, and J. T. Grayston. 1998. Pre-clinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice. Clin. Microbiol. Infect. 4:4S23-4S32.
3. Ellison, J., M. Dean, and D. Goldman. 1993. Efficacy of fluorescence-based PCR-SSCP for detection of point mutations. BioTechniques 4:684-691.
4. Fan, Y., S. Wang, and X. Yang. 1999. Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection. Infect. Immun. 67:6145-6151.
5. Fong, I. W., B. Chiu, E. Viira, D. Jang, and J. B. Mahony. 1999. De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect. Immun. 67:6048-6055.
6. Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Investig. 103:747-753.
7. Kim, D. N., J. Schmee, K. T. Lee, and W. A. Thomas. 1987. Atherosclerotic lesions in the coronary arteries of hyperlipidemic swine. I. Cell increases, divisions, losses and cells of origin in first 90 days of diet. Atherosclerosis 64: 231-242.
8. Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, and E. P. Benditt. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92:6911-6914.
9. Kuo, C. C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841-849.
10. Laitinen, K., A. Laurila, L. Pyhälä, M. Leinonen, and P. Saikku. 1997. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect. Immun. 65:4832-4835.
11. Leinonen, M., E. Linnanmaki, K. Mattila, M. S. Nieminen, V. Valtonen, M. Leirisalo-Repo, and P. Saikku. 1990. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb. Pathog. 1:67-73.
12. Linnanmaki, E., M. Leinonen, K. Mattila, M. S. Nieminen, V. Valtonen, and P. Saikku. 1993. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 4:1130-1134.
13. Lopez-Virella, M. F., and G. Virella. 1985. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin. Immunol. Immunopathol. 37:377-386.
14. Moazed, T., L. A. Campbell, M. E. Rosenfeld, J. T. Grayston, and C. C. Kuo. 1999. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180: 238-241.
15. Moazed, T., C. C. Kuo, J. T. Grayston, and L. A. Campbell. 1997. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175:883-890.
16. Muhlestein, J. B., J. L. Anderson, E. H. Hammond, L. Zhao, S. Trehan, E. Schwobe, and J. F. Carlquist. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633-636.
17. Ramirez, J., and the Chlamydia pneumoniae/Atherosclerosis Study Group. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 125:979-982.
18. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmäki, M. R. Ekman, V. Manninen, M. Manttari, M. H. Frick, and J. K. Huttunen. 1992. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Intern. Med. 116:273-278.
19. Saikku, P., M. Leinonen, K. Mattila, M. R. Ekman, M. S. Nieminen, P. H. Makela, J. K. Huttunen, and V. Valtonen. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983-986.
20. Shor, A., C. C. Kuo, and D. L. Patton. 1992. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82:158-160.
21. Thomas, W. A., K. T. Lee, and D. N. Kim. 1985. Cell population kinetics in atherogenesis. Cell births and losses in intimai cell mass-derived lesions in the abdominal aorta of swine. Ann. N. Y. Acad. Sci. 454:305-315.
22. Velican, D., and C. Velican. 1976. Intimal thickening in developing coronary arteries and its relevance to atherosclerotic involvement. Atherosclerosis 23: 345-355.
23. Wang, S. P., and J. T. Grayston. 1970. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am. J. Ophthalmol. 70:367-374.